Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
41.30
+1.05 (2.60%)
Apr 3, 2025, 3:03 PM EDT - Market open

Cytokinetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
4,8825,5518,1864,3363,8231,471
Upgrade
Market Cap Growth
-32.19%-32.19%88.80%13.41%159.96%134.31%
Upgrade
Enterprise Value
4,6675,4488,3964,2103,6121,201
Upgrade
Last Close Price
40.2547.0483.4945.8245.5820.78
Upgrade
PS Ratio
243.97300.501087.1845.8454.2926.35
Upgrade
PB Ratio
-35.60-41.01-21.19-40.1815.6812.97
Upgrade
P/TBV Ratio
----15.6812.97
Upgrade
P/OCF Ratio
----164.46
Upgrade
EV/Sales Ratio
252.63294.901115.0344.5051.2921.51
Upgrade
Debt / Equity Ratio
-6.82-6.82-1.96-6.951.111.23
Upgrade
Asset Turnover
0.020.020.010.100.100.14
Upgrade
Quick Ratio
6.086.086.009.257.3515.10
Upgrade
Current Ratio
6.176.176.129.407.4515.20
Upgrade
Return on Equity (ROE)
----572.15%-120.54%-248.50%
Upgrade
Return on Assets (ROA)
-30.11%-30.11%-33.73%-21.83%-16.94%-14.26%
Upgrade
Return on Capital (ROIC)
-57.92%-57.92%-61.30%-35.05%-30.40%-31.11%
Upgrade
Earnings Yield
-12.23%-10.62%-6.43%-8.97%-5.63%-8.65%
Upgrade
FCF Yield
-8.29%-7.20%-5.08%-7.17%-5.01%-0.14%
Upgrade
Buyback Yield / Dilution
-16.01%-16.01%-7.46%-16.83%-19.16%-12.07%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q